tirzepatide application (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or De-Risking FDA Abbreviated New Drug

Water is the unsung hero of smooth bowel movements for everyone, especially those on medications affecting digestion

Real-life comparisons emphasize the medication's potential to offer a more balanced approach to diabetes care with the added benefit of weight management

Recent studies indicate that Semaglutide can effectively manage NAFLD by inducing weight loss and improving insulin sensitivity, both crucial in addressing the disease

Hims & Hers Pulls Back GLP-1 Weight-Loss Pill Shortly afterward, Hims & Hers Health abruptly abandoned its plan to launch a compounded version oral weight-loss pill priced as low as $49/month, backing off within days amid regulatory pressure and industry backlash

Increasing heart rate